These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 28166681)

  • 21. New concepts in the immunopathogenesis of multiple sclerosis.
    Hemmer B; Archelos JJ; Hartung HP
    Nat Rev Neurosci; 2002 Apr; 3(4):291-301. PubMed ID: 11967559
    [No Abstract]   [Full Text] [Related]  

  • 22. Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.
    Lehmann-Horn K; Kinzel S; Weber MS
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
    Costanza M; Colombo MP; Pedotti R
    Int J Mol Sci; 2012 Nov; 13(11):15107-25. PubMed ID: 23203114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
    Mc Guire C; Prinz M; Beyaert R; van Loo G
    Trends Mol Med; 2013 Oct; 19(10):604-13. PubMed ID: 24007818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H; Addicks K; Kuerten S
    Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory B cells in experimental autoimmune encephalomyelitis (EAE).
    Ray A; Basu S
    Methods Mol Biol; 2014; 1190():243-55. PubMed ID: 25015285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
    De Santi L; Annunziata P; Sessa E; Bramanti P
    J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis.
    Korn T; Mitsdoerffer M; Kuchroo VK
    Results Probl Cell Differ; 2010; 51():43-74. PubMed ID: 19513635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.
    Mars LT; Saikali P; Liblau RS; Arbour N
    Biochim Biophys Acta; 2011 Feb; 1812(2):151-61. PubMed ID: 20637863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease.
    Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel PR
    J Autoimmun; 1999 Aug; 13(1):11-20. PubMed ID: 10441163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deleterious versus protective autoimmunity in multiple sclerosis.
    Kostic M; Stojanovic I; Marjanovic G; Zivkovic N; Cvetanovic A
    Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B cell recognition of myelin oligodendrocyte glycoprotein autoantigen depends on immunization with protein rather than short peptide, while B cell invasion of the CNS in autoimmunity does not.
    Dang AK; Jain RW; Craig HC; Kerfoot SM
    J Neuroimmunol; 2015 Jan; 278():73-84. PubMed ID: 25595255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cells in multiple sclerosis.
    Severson C; Hafler DA
    Results Probl Cell Differ; 2010; 51():75-98. PubMed ID: 19582415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sclerosis: an altered immune response or an altered stress response?
    van Noort JM
    J Mol Med (Berl); 1996 Jun; 74(6):285-96. PubMed ID: 8862510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immune pathogenesis of experimental autoimmune encephalomyelitis: lessons learned for multiple sclerosis?
    Kuerten S; Lehmann PV
    J Interferon Cytokine Res; 2011 Dec; 31(12):907-16. PubMed ID: 21936633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
    Martin R; McFarland HF
    Crit Rev Clin Lab Sci; 1995; 32(2):121-82. PubMed ID: 7598789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
    Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC
    Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.